Objective: Formulation aims to develop a film that dissolves quickly for advanced
solid dosage forms in order to increase the drug's bioavailability and enhance its
action. Natural gum and artificial polymers were combined to develop films with
the desired properties. Method: Metoclopramide FDF was developed in nine
different formulations (F1–F9) using the solvent casting process. The effect of
varying formulation parameters on the physical and mechanical characteristics of
metoclopramide films was investigated in vitro using phosphate buffer at 6.8 pH.
Several techniques were used to evaluate the films' weight, thickness, tensile
strength, folding durability, and oral dissolving time in order to determine the
best possible formulation. Results: The findings showed that the materials were
employed consistently throughout the whole film in terms of drug content. While
all the formulations had acceptable testing features, formulation F7 was deemed
the most promising due to its 99.12% in-vitro drug release and other
characteristics. All the formulations are shown to obey first-order kinetics and
fickian release. The formulation showed enhanced drug release rates over a 9-
minute period, indicating its adaptability. It contained the ideal polymer
concentrations of Cyamopsis tetragonoloba gum, HPMC, and PEG. Conclusion:
The study suggests that metoclopramide fast-dissolving oral films are the most
effective antiemetic option for quick onset of action and enhanced bioavailability.
Keywords: Fast dissolving films, oral mucosa, metoclopramide, anti-emetic,
Cyamopsis tetragonoloba gum, improved bioavailability, Solvent casting, Filmforming
polymers